Popular pharmaceutical target in cells may prove even more useful
Researchers have identified a new signaling process involving G protein-coupled receptors (GPCRs), a cellular target already exploited by hundreds of diverse drugs. The discovery opens the possibility of new therapies, including for multiple forms of cancer.
Materials provided by University of California – San Diego. Original written by Scott LaFee. Note: Content may be edited for style and length.
Source link aaaaa